Gilgamesh pharmaceuticals stock
WebGilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom management to a focus on rapid-acting and durable therapies targeting the fundamental drivers of disease. Gilgamesh's discovery platform provides a state-of-the-art neurocircuitry-focused … team - Gilgamesh Pharma Pipeline - Gilgamesh Pharma Contact Us - Gilgamesh Pharma WebPharmaceutical. Headquarters Regions Greater New York Area, East Coast, Northeastern US. Founded Date Jan 1, 2024. Founders Andrew Kruegel, Dalibor Sames, Jeff Witkin, Jonathan Sporn, Mike Cunningham. …
Gilgamesh pharmaceuticals stock
Did you know?
WebMay 16, 2024 · Compass Pathways (stock ticker NASDAQ: CMPS) has launched clinical trials in 20 countries with a focus on treatment-resistant depression. In addition, Johnson … WebDec 15, 2024 · Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company… Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property …
WebMay 6, 2024 · Press Release. NEW YORK, May 6, 2024 /PRNewswire/ — Gilgamesh Pharmaceuticals, a mental health science focused biotechnology company utilizing psychedelic-related medicines for the treatment of neuropsychiatric conditions, today announced the closing of a $27 million Series A round of funding led by Prime Movers … WebDec 15, 2024 · NEW YORK, Dec. 15, 2024 /PRNewswire/ -- Gilgamesh Pharmaceuticals, a biotechnology company developing a portfolio of rapid-acting and durable treatments …
WebGilgamesh is positioned to be a differentiated leader in the psychedelic assisted global mental health care revolution. Phase 1 studies for the two lead programs to begin later this year (GM-1020: Oral NMDAR Antagonist, GM-2505: 5-HT2A Agonist/5-HT Releaser). Lead molecules have been optimized for efficacy, durability, safety allowing for broad ... WebJul 10, 2024 · Stock # of Shares Authorized Par Value Dividend Rate (%) Original Issue Price Liquidation Liquidation Pref. Multiple Conversion Price % Owned; Series B: …
WebJan 22, 2024 · Gilgamesh Pharmaceuticals Share Price and News. Gilgamesh is a serious mental health science focused, preclinical biotechnology company. We...
WebMar 24, 2024 · Novel treatments for depression and other neuropsychiatric disordersNEW YORK, March 24, 2024 /PRNewswire/ -- Gilgamesh Pharmaceuticals, a mental h... toyo ito museum of architecture planWebJan 22, 2024 · Gilgamesh is a serious mental health science focused, preclinical biotechnology company. We have a disciplined focus on developing innovative new … toyo jobs white gaWebDec 15, 2024 · NEW YORK, Dec. 15, 2024 /PRNewswire/ -- Gilgamesh Pharmaceuticals, a biotechnology company developing a portfolio of rapid-acting and durable treatments for depression and other mental health ... toyo kerosene heaters for saleWebOct 14, 2024 · Funding. Gilgamesh Pharmaceuticals has raised a total of $68.6M in funding over 7 rounds. Their latest funding was raised on Dec 15, 2024 from a Series B round. Gilgamesh Pharmaceuticals is funded by 18 investors. Prime Movers Lab and JLS Fund are the most recent investors. toyo l730 heaterWebDec 20, 2024 · Psychedelics biotech company Gilgamesh Pharmaceuticals announced the closing of a $39 million Series B financing round led by Prime Movers Lab and joined by Alumni Ventures, Palo Santo, Negev ... toyo kerosene heaterWebMay 6, 2024 · NEW YORK, May 6, 2024 /PRNewswire/ -- Gilgamesh Pharmaceuticals, a mental health science focused biotechnology company utilizing psychedelic-related … toyo kerosene hot water heatersWebMay 16, 2024 · Compass Pathways (stock ticker NASDAQ: CMPS) has launched clinical trials in 20 countries with a focus on treatment-resistant depression. In addition, Johnson & Johnson is also active in the … toyo knife co. ltd